Sydney, AUSTRALIA – Philips Healthcare Australia, a global leader in health technology, today announced that it successfully met all the targets set out in its 2016 - 2020 ‘Healthy people, Sustainable planet’ program. Key achievements of the program include carbon neutrality in its operations, 100% electricity from renewable sources, over 70% of sales from Green Products and Services [1], 15% of sales coming from circular revenues, recycling 90% of its operational waste, and sending zero waste to landfill.
“I am pleased that we have delivered on all the targets set out in our Healthy people, Sustainable planet program, making Philips one of the first health technology companies in the world that has become carbon neutral in its operations,” said Frans van Houten, CEO of Royal Philips
Frans van Houten
CEO of Royal Philips.
“Our current integrated ESG framework builds on this success, and we are determined to join forces with all necessary stakeholders, public and private, to drive environmental, social and governance priorities and generate global impact. With the COVID-19 pandemic and climate change exposing the risks in terms of people’s health and access to quality healthcare, we are committed to building inclusive and resilient healthcare systems, while reducing our dependency on natural resources.” Philips’ Environmental, Social and Governance update is an integral part of the Philips Annual Report 2020, which was published earlier today. Highlights include: Environmental: Social: Governance: Raising the bar As part of its ongoing commitment to making the world healthier and more sustainable through innovation, Philips will continue to build on the success of the program with an enhanced and fully integrated approach to doing business responsibly and sustainably. As announced last September, this new framework comprises a comprehensive set of targets, commitments and action plans across all the Environmental, Social and Governance dimensions that will drive further growth while acting responsibly towards the planet and society. Human Rights Report Today, Philips also published its latest Human Rights Report 2020, which contains information about the company’s progress with regard to identifying and mitigating (potential) adverse human rights impacts in Philips’ own operations and its value chain. Moreover, Philips issued new policy statements on human rights, fair employment, and inclusion and diversity, covering aspects such as equal opportunity, fair and equal pay, workplace harassment/intimidation, child labor, forced labor, and working time directives. Global recognition Philips received further recognition for its ESG performance: top positions in the Dow Jones Sustainability Index, and Sustainalytics rankings; eight consecutive years on the CDP Climate Change A-list; greenhouse gas reduction targets approved by the Science Based Targets initiative. Philips also achieved second place in 2020 on Wall Street Journal’s 100 Most Sustainably Managed Companies in the World.
The Philips IntelliSite Pathology Solution will streamline and centralise the operational processing workflow and enable greater consistency in the quality processing of histology slides via a digital image. At Philips we’ve identified digital pathology as a critical element in the growing digitisation of the healthcare continuum. “We’re excited to be working with Gribbles Veterinary to provide pathologists with access to real-time clinical information in one place – across modalities, time zones, and technologies.”
Matt Moran
General Manager ANZ
“At Gribbles Veterinary, we’re committed to providing animal health professionals with the best pathology service, enabling them to deliver the highest standard of care. The COVID-19 pandemic highlighted the critical need to digitise our diagnostic capabilities and ensure continuity of our service and care delivery.” said James Richardson, General Manager of Gribbles Veterinary, adding that “This technology not only improves the customer experience, thanks to the quality and versatility of the image provided to the pathologist, it also enhances the staff experience by enabling more flexibility in the way, and place, pathologists collaborate and work. This is an important factor for us as we continue to position ourselves as the best place to work”.
James Richardson
General Manager of Gribbles Veterinary
The Philips IntelliSite Pathology Solution in Gribbles Laboratories represents the first development in the newly trusted partnership between Royal Philips and Gribbles Veterinary. This installation also represents another step towards accelerated digital adoption in healthcare and healthcare services in New Zealand.
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 19.5 billion and employs approximately 82,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.